Login / Signup

Effect of Fecal Microbiota, Live-Jslm (REBYOTA [RBL]) on Health-Related Quality of Life in Patients With Recurrent Clostridioides difficile Infection: Results From the PUNCH CD3 Clinical Trial.

Kevin W GareyErik R DubberkeAmy GuoAdam HarveyMin YangViviana García-HortonMirko FillbrunnHongjue WangGlenn S TillotsonLindy L BanckePaul Feuerstadt
Published in: Open forum infectious diseases (2023)
ClinicalTrials.gov NCT03244644 (https://clinicaltrials.gov/ct2/show/NCT03244644).
Keyphrases
  • clostridium difficile
  • clinical trial
  • image quality
  • computed tomography
  • dual energy
  • contrast enhanced
  • phase ii
  • study protocol
  • double blind
  • nk cells
  • magnetic resonance imaging